Wall Street JournalToddler's Death Stirs Ire in ChinaWall Street JournalThe two-year-old, Wang Yue, had been in critical condition and verging on brain death since arriving at a military hospital in the city of Guangzhou a week ago. She succumbed t…
Cardiac Troponin Predicts Mortality in Acute Heart Failure – Doctors Lounge
Cardiac Troponin Predicts Mortality in Acute Heart FailureDoctors LoungeA sensitive cardiac troponin I assay can predict mortality risk for patients with acute heart failure, according to a study published online Oct. 11 in the Journal of Internal Medi…
Study finds drop in heart failure hospitalizations – Nurse.com
Study finds drop in heart failure hospitalizationsNurse.comBetween 1998 and 2008, heart failure-related hospitalizations declined substantially among Medicare patients, but at a lower rate for black men, according to a study. The study also found that …
Abbott Touts $4 Billion in Drug Sales as It Pitches Spinoff – BusinessWeek
Abbott Touts $4 Billion in Drug Sales as It Pitches SpinoffBusinessWeekDaclizumab, the multiple sclerosis treatment, should be on sale by 2015, as will compounds being tested for hepatitis C, the company said. At the same time, the new drug business wi…
Commonly used 3-drug regimen for idiopathic pulmonary fibrosis found harmful – EurekAlert (press release)
Commonly used 3-drug regimen for idiopathic pulmonary fibrosis found harmfulEurekAlert (press release)The trial found that people with IPF receiving a currently used triple-drug therapy consisting of prednisone, azathioprine, and N-acetylcysteine (NAC)…
Heart failure strikes fewer seniors – American Council on Science and Health
Heart failure strikes fewer seniorsAmerican Council on Science and HealthNow, a group of Yale researchers has found that the percentage of senior citizens hospitalized for heart failure has dropped by nearly one third since 1998. The study, published i…
Abbott Touts $4 Billion in New Drug Sales as It Pitches Spinoff – Bloomberg
Abbott Touts $4 Billion in New Drug Sales as It Pitches SpinoffBloombergDaclizumab, the multiple sclerosis treatment, should be on sale by 2015, as will compounds being tested for hepatitis C, the company said. At the same time, the new drug business w…
'No cure to UPA's multiple organ failure' – Daily Pioneer
Tehelka'No cure to UPA's multiple organ failure'Daily PioneerLed by the “weakest Prime Minister ever”, the UPA Government was suffering from a “multiple organ failure” and was showing all symptoms of a “terminal decline”, with i…
Jefferies Analysts Raise Alexion Pharmaceuticals (ALXN) EPS Estimates – LocalizedUSA
Jefferies Analysts Raise Alexion Pharmaceuticals (ALXN) EPS EstimatesLocalizedUSA… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the therapeuti…
Ocrelizumab Benefits in MS Maintained to 96 Weeks – Medscape
Ocrelizumab Benefits in MS Maintained to 96 WeeksMedscapeRituximab, an anti-CD20 monoclonal antibody that selectively reduces CD20-positive B-cells, showed "proof of concept" efficacy in MS in phase 1 and 2 investigations, they say. Ocrelizum…